1. Home
  2. FOA vs OBIO Comparison

FOA vs OBIO Comparison

Compare FOA & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$22.26

Market Cap

221.6M

Sector

Finance

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.44

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOA
OBIO
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.6M
253.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FOA
OBIO
Price
$22.26
$4.44
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$26.00
$14.25
AVG Volume (30 Days)
48.1K
174.0K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
216.95
33.13
EPS
0.41
N/A
Revenue
$497,432,000.00
$33,482,000.00
Revenue This Year
$0.58
N/A
Revenue Next Year
$6.91
$12.43
P/E Ratio
$53.66
N/A
Revenue Growth
47.09
1169.22
52 Week Low
$15.77
$2.20
52 Week High
$29.79
$5.42

Technical Indicators

Market Signals
Indicator
FOA
OBIO
Relative Strength Index (RSI) 46.01 65.89
Support Level $22.10 $4.07
Resistance Level $24.03 $4.76
Average True Range (ATR) 1.18 0.19
MACD -0.19 0.06
Stochastic Oscillator 27.38 76.37

Price Performance

Historical Comparison
FOA
OBIO

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: